This Guidance document focuses on the antioestrogenic protocol; it is the outcome of the experience gained during the validation test programme and the results obtained thereby with the use of a strong oestrogen receptor antagonist. Due to insufficient validation of this antioestrogenic protocol, this Guidance Document is provided for experimental purpose only. The test will provide supporting evidence in relation to antioestrogenic activity.
Guidance Document on the Uterothrophic Bioassay ‑ Procedure to Test for Antioestrogenicity
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
10 August 2026179 Pages
-
Report10 August 202653 Pages
-
15 December 2025169 Pages
-
Report3 December 2025136 Pages
Related publications
-
10 August 2026179 Pages
-
Report10 August 202653 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
2 July 202651 Pages
-
2 July 2026115 Pages